Science Advisory Committee on Health Products Containing Cannabis (SAC-HPCC): Agenda for December 10, 2021 web conference

1

Welcome and introductory remarks
Presenters: Committee Co-Chairs

1. Tech verification
2. Meeting recording

2

Administrative items
Presenters: Committee Co-Chairs

1. Updates to declarations of affiliations and interests
2. Approval of agenda and November 5, 2021 record of proceedings

3

Committee review and discussion of background section of report
Facilitators: Committee Co-Chairs

1. Review of outline and structure of section
2. Discussion of specific areas where clarifications and more details are required
3. Identification of any additional information to be included

4

Committee review and discussion of report section on the safety of CBD when used for therapeutic purposes in humans
Facilitators: Committee Co-Chairs

1. Review of outline and structure of section
2. Discussion of specific areas where clarifications and more details are required
3. Identification of any additional information to be included
4. Discussion of related supporting evidence

5

Break

6

Committee review and discussion of report section on the efficacy of CBD when used for therapeutic purposes in humans
Facilitators: Committee Co-Chairs

1. Review of outline and structure of section
2. Discussion of specific areas where clarifications and more details are required
3. Identification of any additional information to be included
4. Discussion of related supporting evidence

7

Break

8

Committee review and discussion of report sections on CBD quality and evidence standards
Facilitators: Committee Co-Chairs

1. Review of structure of sections
2. Discussion of specific areas where clarifications and more details are required
3. Identification of any additional information to be included
4. Discussion of related supporting evidence

9

Committee review and discussion of report section on considerations for CBD use in animal
Facilitators: Committee Co-Chairs

1. Summary of the progress to date of the Subcommittee on animal health
2. Review of outline and structure of section
3. Discussion of specific areas where clarifications and more details are required
4. Identification of any additional information to be included
5. Discussion of related supporting evidence

10

Committee discussion on THC and other non-CBD phytocannabinoids
Facilitators: Committee Co-Chairs

1. Discussion of available safety and efficacy evidence

11

Wrap up and next steps
Presenters: Committee Co-Chairs